source
- Weekly roundup: Experts debate China biotech work ethic and a stalled megamergerThe Endpoints News team hosted a panel of industry experts in Cambridge, Massachusetts, to examine the future of biotech in China. Participants highlighted concerns about the country’s work ethic a…
- Senate introduces BINSA bill to tighten review of China biotech and pharma transactionsThe U.S. Senate has introduced the Biotech Innovation and National Security Act (BINSA), a bill that would tighten oversight of biotech and pharmaceutical transactions involving China. The proposa…